The impact of cardiovascular diseases on hearing deterioration : a 13-year follow-up study
Lohi, Venla; Ohtonen, Pasi; Sorri, Martti; Mäki-Torkko, Elina; Hannula, Samuli (2021-11-09)
Venla Lohi, Pasi Ohtonen, Martti Sorri, Elina Mäki-Torkko & Samuli Hannula (2022) The impact of cardiovascular diseases on hearing deterioration: a 13-year follow-up study, International Journal of Audiology, 61:10, 826-831, DOI: 10.1080/14992027.2021.1998838
© 2021 British Society of Audiology, International Society of Audiology, and Nordic Audiological Society. This is an Accepted Manuscript version of the following article, accepted for publication in International Journal of Audiology. Venla Lohi, Pasi Ohtonen, Martti Sorri, Elina Mäki-Torkko & Samuli Hannula (2021) The impact of cardiovascular diseases on hearing deterioration: a 13-year follow-up study, International Journal of Audiology, DOI: 10.1080/14992027.2021.1998838. It is deposited under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
https://creativecommons.org/licenses/by-nc/4.0/
https://urn.fi/URN:NBN:fi-fe2021112557050
Tiivistelmä
Abstract
Objective: To study the impact of cardiovascular diseases (CVDs) on hearing deterioration among ageing adults in a longitudinal setting. Furthermore, to describe the pure tone threshold changes at the 0.125–8 kHz frequency range over 13 years.
Design: A population-based follow-up study.
Study sample: A random sample of 850 adults, of whom 559 participated in the follow-up study. Otological examination, a structured interview, and pure tone audiometry were conducted. Multivariate regression models were used to estimate the effect of CVD (participants had at least one cardiovascular condition) on hearing deterioration of the better ear hearing level (BEHL), defined as a change in the pure-tone average (PTA) of the frequencies 0.5, 1, 2, and 4 kHz and separately at the lower (0.125, 0.25, and 0.5 kHz) and higher (4, 6, and 8 kHz) frequencies.
Results: In the multivariable-adjusted analysis, the BEHL change at 13 years was 0.7 dB greater among participants with CVD (p = 0.3). The mean BEHL change during the 13-year follow-up was 12.0 dB (95% CI 11.4–12.6) among all participants.
Conclusions: No significant association between CVD and hearing threshold changes was found.
Kokoelmat
- Avoin saatavuus [36502]
